 | Up a level |
Jump to: 2021
Number of items: 1.
2021
Frost, Nikolaj 
ORCID: 0000-0001-7452-7129, Christopoulos, Petros ORCID: 0000-0002-7966-8980, Kauffmann-Guerrero, Diego, Stratmann, Jan, Riedel, Richard, Schaefer, Monica, Alt, Jurgen, Gutz, Sylvia, Christoph, Daniel C., Laack, Eckart, Faehling, Martin, Fischer, Richard, Fenchel, Klaus, Haen, Sebastian, Heukamp, Lukas, Schulz, Christian and Griesinger, Frank
(2021).
Lorlatinib in pretreated ALK- or ROS1-positive lung cancer and impact of TP53 co-mutations: results from the German early access program.
Ther. Adv. Med. Oncol., 13.
LONDON:
SAGE PUBLICATIONS LTD.
ISSN 1758-8359